æ≈æ—π∏å ∫ÿ≠¡“°
•
Polpun Boonmak
∫∑øóôπøŸ«‘™“°“√ • Review Article
¿“«–À—«„®À¬ÿ¥‡µâπ∑’ˉ¡à§“¥§‘¥·≈–«‘ —≠≠’«‘∑¬“
æ≈æ—π∏å ∫ÿ≠¡“°
¿“§«‘™“«‘ —≠≠’«‘∑¬“ §≥–·æ∑¬»“ µ√å ¡À“«‘∑¬“≈—¬¢Õπ·°àπ
Unexpected Cardiac Arrest and Anesthesia
Polpun Boonmak
Department of Anesthesiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002 Thailand
‚¥¬∑—Ë«‰ª¿“«–À—«„®À¬ÿ¥‡µâπ À¡“¬∂÷ß ¿“«–·∑√°´âÕπ
∑’Ë∑”„ÀâÀ—«„® à߇≈◊Õ¥‰ª‡≈’Ȭß√à“ß°“¬‰¡à‡æ’¬ßæÕ ´÷Ëß®”‡ªìπ
µâÕ߉¥â√—∫°“√°¥Àπâ“Õ° ‚¥¬Õ“®√à«¡°—∫ °“√„À⬓ ·≈–
°“√™ÁÕ°À—«„®¥â«¬‰øøÑ“4-6 ´÷Ë߇√“Õ“®æ∫§≈◊Ëπ‰øøÑ“À—«„®
‰¥âÀ≈“°À≈“¬µ—ßÈ ·µà§≈◊πË ‰øøÑ“À—«„®ª°µ‘ ‰ª®π∂÷ߧ≈◊πË ‰øøÑ“
·∫∫ ventricular fibrillation ”À√—∫¿“«–À—«„®À¬ÿ¥‡µâπ
∑’Ë ‰ ¡à § “¥§‘ ¥‡ªì π ∂“π°“√≥å ∑’Ë „ Àâ ° “√¥Ÿ · ≈ºŸâ ªÉ « ¬≈”∫“°
‡π◊Ë Õ ß®“°‰¡à “¡“√∂‡µ√’ ¬ ¡°“√≈à « ßÀπâ “ ®÷ ß ¢“¥·§≈π
∑—Èß°”≈—ß§π ¬“ Õÿª°√≥åµà“ßÊ ∑”„Àâ‡√“®”‡ªìπµâÕß¡’§«“¡
‡¢â“„®‡°’¬Ë «°—∫≈—°…≥–¿“«–À—«„®À¬ÿ¥‡µâπ∑’‰Ë ¡à§“¥§‘¥ ‡æ◊ÕË „Àâ
“¡“√∂¥Ÿ·≈ºŸâªÉ«¬‰¥â„π ∂“π°“√≥å∑’Ë¡’∑√—欓°√®”°—¥
‡π◊ÈÕÀ“
1. §«“¡ ”§— ≠ ·≈–§”®”°— ¥ §«“¡¢Õß¿“«–À— « „®
À¬ÿ¥‡µâπ∑’ˉ¡à§“¥§‘¥
2. Õÿ∫—µ‘°“√≥å¢Õß¿“«–À—«„®À¬ÿ¥‡µâπ∑’ˉ¡à§“¥§‘¥
3. “‡Àµÿ¿“«–À—«„®À¬ÿ¥‡µâπ∑’ˉ¡à§“¥§‘¥
4. °“√ªÑÕß°—π°“√‡°‘¥¿“«–À—«„®À¬ÿ¥‡µâπ∑’ˉ¡à§“¥§‘¥
5. °“√¥Ÿ·≈ºŸªâ «É ¬‡¡◊ÕË ‡°‘¥¿“«–À—«„®À¬ÿ¥‡µâπ∑’‰Ë ¡à§“¥§‘¥
°“√«“߬“√–ß—∫§«“¡√Ÿâ ÷°„πªí®®ÿ∫—π¡’§«“¡°â“«Àπâ“
‡ªìπÕ¬à“ß¡“° ‚¥¬∂◊Õ«à“‡ªìπÀ—µ∂°“√∑’Ë¡’§«“¡ª≈Õ¥¿—¬ Ÿß
ºŸâªÉ«¬∑—Ë«‰ª®–¡’Õ—µ√“°“√‡ ’¬™’«‘µ∑’˵˔ ´÷Ëß¡’Õ—µ√“πâÕ¬≈ß
°«à “ „πÕ¥’ µ ∑—È ß π’È ‡ °‘ ¥ ®“°°“√«“߬“√–ß— ∫ §«“¡√Ÿâ ÷ ° ¡’
¡“µ√∞“π°“√¥Ÿ·≈ºŸªâ «É ¬∑’Ë ßŸ ¢÷πÈ ºŸªâ «É ¬·µà≈–√“¬®–¡’°“√¥Ÿ·≈
Õ¬à“ß„°≈♑¥‚¥¬∫ÿ§≈“°√∑’Ë¡’§«“¡ “¡“√∂1 ¡’°“√‡ΩÑ“√–«—ß
‚¥¬Õÿª°√≥å∑—π ¡—¬ ¡’°“√‡≈◊Õ°„™â¬“À√◊Õ‡∑§π‘§∑’Ë¡’¿“«–
·∑√°´âÕπµË” ·≈–‡∑§π‘§°“√ºà“µ—¥∑’Ë¡’°“√æ—≤π“Õ¬à“ß¡“°
·≈–‡¡◊ËÕ‡°‘¥¿“«–·∑√°´âÕπ∫ÿ§≈“°√∑“ß«‘ —≠≠’¡’ “¡“√∂
„π°“√¥Ÿ·≈ªÑÕß°—π ·°â‰¢°àÕπ‡°‘¥¿“«–À—«„®À¬ÿ¥‡µâπ1, 2
Õ¬à“߉√°Áµ“¡ ¿“«–À—«„®À¬ÿ¥‡µâπ∑—Èß„π¢≥–ºà“µ—¥·≈–
À≈—ßºà“µ—¥°Á¬—ߧߡ’ ·¡â«à“®–¡’Õÿ∫—µ‘°“√≥å≈¥≈ß°«à“„πÕ¥’µ
‡π◊ËÕß®“°¡’À≈“¬ªí®®—¬∑’ˇ°’ˬ«¢âÕß∑—Èß®“°µ—«ºŸâªÉ«¬ Õ“¬ÿ
‚√§µà“ßÊ ®“°‡∑§π‘§∑“ß«‘ —≠≠’ ®“°°“√ºà“µ—¥∑’Ë´—∫´âÕπ
®“°°“√«“߬“√–ß— ∫ §«“¡√Ÿâ ÷ ° πÕ°Àâ Õ ßºà “ µ— ¥ ∑’Ë ¡ “°¢÷È π
√«¡∑—Èß®“°§«“¡º‘¥æ≈“¥µà“ßÊ ∑’ËÕ“®‡°‘¥¢÷Èπ ‚¥¬∑’Ë “‡Àµÿ
‡À≈à“π’∫È “ßÕ¬à“ß “¡“√∂ªÑÕß°—π‰¥â ¢≥–∑’∫Ë “ßÕ¬à“߇ªìπ‡√◊ÕË ß
ÿ¥«‘ —¬ ‰¡à “¡“√∂§“¥°“√≥å≈à«ßÀπâ“À√◊ÕªÑÕß°—π‰¥â ¥—ßπ—Èπ
∫ÿ§≈“°√∑“ß«‘ —≠≠’∑ÿ°§π§«√®–µâÕß¡’§«“¡√Ÿâ„π°“√¥Ÿ·≈
ªÑ Õ ß°— π ·≈–·°â ‰ ¢¿“«–À— « „®À¬ÿ ¥ ‡µâ 𠉥â Õ ¬à “ ߇À¡“– ¡
´÷Ëß∫ÿ§≈“°√∑“ß«‘ —≠≠’¡’»—°¬¿“æ„π°“√¥Ÿ·≈¿“«–À—«„®
À¬ÿ¥‡µâπ‰¥âÕ¬à“ß¡’ª√– ‘∑∏‘¿“æ1-3
»√’π§√‘π∑√凫™ “√ 2551; 23(2)
Õÿ∫—µ‘°“√≥å¢Õß¿“«–À—«„®À¬ÿ¥‡µâπ∑’ˉ¡à§“¥§‘¥
”À√—∫ß“π∑“ߥâ“π«‘ —≠≠’«‘∑¬“‡√‘Ë¡¡’√“¬ß“πºŸâªÉ«¬¡’
¿“«–À—«„®À¬ÿ¥‡µâπµ—Èß·µà∑»«√√…∑’Ë 1940 ‚¥¬√“¬ß“π
„πºŸâªÉ«¬∑’Ë¡’ ÿ¢¿“æ·¢Áß·√ß∑’Ë¡“√—∫°“√ºà“µ—¥‡≈Á° ‚¥¬°“√„™â
¬“¥¡ ≈∫ chloroform À≈—ß®“°π—Èπ°Á¡’√“¬ß“π°“√‡°‘¥¿“«–
À—«„®À¬ÿ¥‡µâπÕ¬à“ßµàÕ‡π◊ËÕß∑’ˇ°’ˬ«¢âÕß°—∫°“√«“߬“√–ß—∫
§«“¡√Ÿâ ÷°∑ÿ°«‘∏’ „π∑ÿ°™à«ß¢Õß°“√«“߬“√–ß—∫§«“¡√Ÿâ ÷°
„πºŸâªÉ«¬∑ÿ°≈—°…≥– „π‡°◊Õ∫∑ÿ°°“√ºà“µ—¥ ·µà‚¥¬∑—Ë«‰ª
Õÿ ∫— µ‘ ° “√≥å ¿ “«–À— « „®À¬ÿ ¥ ‡µâ π „πºŸâ ªÉ « ¬∑’Ë ¡ “√— ∫ °“√«“ß
¬“√–ß—∫§«“¡√Ÿâ ÷°„πÕ‡¡√‘°“‡Àπ◊Õ·≈–¬ÿ‚√ª®–Õ¬Ÿà√–À«à“ß
0.69 - 4.3 µàÕºŸâªÉ«¬ 10,000 √“¬ ∑’Ë¡“√—∫∫√‘°“√5,7,8 ‚¥¬
Õ“®µà “ ß°— 𠵓¡ª√–‡∑»·≈– ∂“π∑’Ë ∑’Ë »÷ ° …“‡π◊Ë Õ ß®“°¡’
À≈“¬ªí®®—¬∑’ˇ°’ˬ«¢âÕß
‡¡◊ÕË »÷°…“‡©æ“–„π°≈ÿ¡à ∑’¡Ë §’ «“¡‡ ¬’Ë ß ßŸ ®–æ∫Õÿ∫µ— °‘ “√≥å
‡æ‘Ë¡¢÷È𠇙àπ °“√ºà“µ—¥À—«„® (127 µàÕºŸâªÉ«¬ 10,000 √“¬)
ºŸâªÉ«¬‡¥Á° ºŸâªÉ«¬ ŸßÕ“¬ÿ ‡ªìπµâπ ·µà‡¡◊ËÕ»÷°…“µ“¡«‘∏’°“√
„À⬓√–ß—∫§«“¡√Ÿâ ÷°æ∫«à“ general anesthesia ¡’Õÿ∫—µ‘°“√≥å
∑’Ë≈¥≈ß°«à“ 20 ªï∑’˺à“π¡“ ¢≥–∑’Ë regional anesthesia ·≈–
•
Srinagarind Med J 2008; 23(2)
215
¿“«–À—«„®À¬ÿ¥‡µâπ∑’ˉ¡à§“¥§‘¥·≈–«‘ ≠
— ≠’«‘∑¬“
•
monitored anesthesia care ¬—ߧߡ’Õÿ∫—µ‘°“√≥å∑’Ë„°≈⇧’¬ß°—∫
„πÕ¥’µ §◊Õ ª√–¡“≥ 1.5 ·≈– 0.7 µàÕºŸâªÉ«¬ 10,000 √“¬
µ“¡≈”¥—∫ ®“°°“√»÷°…“æ∫«à“¿“«–À—«„®À¬ÿ¥‡µâπ «à π„À≠à
∑’‡Ë °‘¥‰¡à‰¥â¡’ “‡Àµÿ‚¥¬µ√ß®“°«‘ ≠
— ≠’8 ´÷ßË ¿“«–À—«„®À¬ÿ¥‡µâπ
∑’Ë — ¡ æ— π ∏å °— ∫ «‘ — ≠ ≠’ ‚ ¥¬µ√ß„πºŸâ ªÉ « ¬∑—Ë « ‰ªæ∫ª√–¡“≥
0.65 - 1 µàÕºŸâªÉ«¬ 10,000 √“¬ 5, 9 ·≈–‡¡◊ËÕ»÷°…“‡©æ“–„π
ºŸâªÉ«¬‡¥Á°®–¡’Õÿ∫—µ‘°“√≥å Ÿß¢÷Èπ §◊Õ 1.4 - 4.6 µàÕºŸâªÉ«¬
10,000 √“¬ 8, 10 ”À√— ∫ „πª√–‡∑»‰∑¬°“√»÷ ° …“¢Õß
√“™«‘ ∑ ¬“≈— ¬ «‘ — ≠ ≠’ · æ∑¬å · Àà ß ª√–‡∑»‰∑¬‡°’Ë ¬ «°— ∫ °“√
‡ ’¬™’«‘µ„π√–À«à“ß°“√«“߬“√–ß—∫§«“¡√Ÿâ ÷° æ∫Õ—µ√“µ“¬
∑’ˇ°’ˬ«¢âÕß°—∫«‘ —≠≠’ 1.7 µàÕºŸâªÉ«¬ 10,000 √“¬11 ”À√—∫
¿“«–À—«„®À¬ÿ¥‡µâπ∑’ˉ¡à§“¥§‘¥ À≈“¬°“√»÷°…“‰¡à‰¥â√–∫ÿ
™—¥‡®π ·µà¡’°“√»÷°…“„πºŸâªÉ«¬∑—Ë«‰ª∑’Ë¡’ ASA physical status
µË”∑’Ë¡“√—∫°“√ºà“µ—¥ ´÷Ëß®—¥«à“‡ªìπ°≈ÿà¡∑’Ë¡’§«“¡‡ ’ˬߵ˔
´÷Ë ß ∂â “ ‡°‘ ¥ ¿“«–À— « „®À¬ÿ ¥ ‡µâ π ¡— ° ‡ªì π °√≥’ ∑’Ë ‰ ¡à § “¥§‘ ¥
¡’√“¬ß“πÕÿ∫—µ‘°“√≥åª√–¡“≥ 0.99 µàÕºŸâªÉ«¬ 10,000 √“¬3
∑”„Àâ√à“ß°“¬¢“¥ÕÕ°´‘‡®π‡≈’È¬ß à«πµà“ßÊ ·≈–¡’Õÿ≥À¿Ÿ¡‘
°“¬µË” ¢“¥ ¡¥ÿ≈‡°≈◊Õ·√à “‡ÀµÿÀ≈—°Õ’°Õ¬à“ß §◊Õ ¿“«–
¢“¥ÕÕ°´‘‡®π„π√–À«à“ß·≈–À≈—ß°“√«“߬“√–ß—∫§«“¡√Ÿâ ÷°
´÷Ëß “‡Àµÿ∑’Ëæ∫∫àÕ¬ ‰¥â·°à °“√„ à∑àՙ૬À“¬„®‰¡à ”‡√Á®
°“√™à«¬À“¬„®‰¡à‰¥â °“√„ ∑à Õà ™à«¬À“¬„®≈ß°√–‡æ“–Õ“À“√
∑à Õ ™à « ¬À“¬„®À≈ÿ ¥ ”≈— ° ‡»…Õ“À“√ laryngospasm,
bronchospasm ºŸªâ «É ¬À“¬„®‰¡à‡æ’¬ßæÕÀ√◊ÕºŸªâ «É ¬À¬ÿ¥À“¬„®
À≈—ßºà“µ—¥ Õÿª°√≥å„ÀâÕÕ°´‘‡®π∑”ß“πº‘¥ª°µ‘ πÕ°®“°π’È
‡°‘¥®“° ¿“æ√à“ß°“¬¢ÕߺŸªâ «É ¬‰¡à¥°’ Õà πºà“µ—¥ ¡’§«“¡√ÿπ·√ß
¢Õß‚√§¡“° ‡™àπ ºŸâªÉ«¬‚√§À—«„®∑’Ë¡’À—«„®‡µâπº‘¥ª°µ‘ À—«„®
¢“¥‡≈◊Õ¥ °“√‡°‘¥ pulmonary embolism ·≈–À—«„®≈⡇À≈«
‡ªìπµâπ ·≈–¬—ß¡’ “‡ÀµÿÕ◊ËπÊ Õ’° ‡™àπ °“√§«∫§ÿ¡§«“¡¥—π
‚≈À‘µ‰¡à‰¥â∑—Èß Ÿß·≈–µË” ®“°¬“µà“ßÊ à«π®“°º≈°“√»÷°…“
¢Õß√“™«‘∑¬“≈—¬«‘ ≠
— ≠’·æ∑¬å·Ààߪ√–‡∑»‰∑¬ æ∫«à“ “‡Àµÿ
à«π„À≠à‡°‘¥®“°°“√‡ ’¬‡≈◊Õ¥¡“° ‚¥¬¡’ “‡ÀµÿÕ◊ËπÊ ‡™àπ
°“√¢“¥ÕÕ°´‘‡®π À—«„®≈⡇À≈« ‡ªìπµâπ ·≈– “‡Àµÿ∑Ë’ ”§—≠
Õ’°Õ¬à“ßÀπ÷Ëß∑’Ëæ∫‰¥â·≈–√“¬ß“πº≈πâÕ¬ §◊Õ §«“¡º‘¥æ≈“¥
®“°∫ÿ§≈“°√ ‚¥¬¡’Õÿ∫—µ‘°“√≥å·µ°µà“ß°—π¢÷Èπ°—∫°“√√“¬ß“π
‚¥¬∫“ß°“√»÷°…“Õ“®æ∫¡“°∂÷ß√âÕ¬≈– 70 ´÷ËßÕ“®‡ªìπ®“°
°“√ª√–¡“∑ ≈–‡≈¬ ‰¡à√Õ∫§Õ∫ √Ÿâ‡∑à“‰¡à∂÷ß°“√≥å
„πºŸâªÉ«¬‡¥Á°æ∫«à“ “‡Àµÿ∑’Ëæ∫∫àÕ¬§≈⓬°—∫ºŸâ„À≠à §◊Õ
°“√æ√àÕ߇≈◊Õ¥·≈– “√πÈ” æ∫√âÕ¬≈– 41 ·≈⫵“¡¡“¥â«¬
√–∫∫À“¬„®≈⡇À≈«æ∫√âÕ¬≈– 2718 (´÷Ëß„π∫“ß°“√»÷°…“
æ∫¡“°°«à“°“√æ√àÕ߇≈◊Õ¥19)
≈—°…≥–§≈◊Ëπ‰øøÑ“À—«„®∑’Ëæ∫∫àÕ¬‡¡◊ËÕ‡°‘¥¿“«–À—«„®
À¬ÿ¥‡µâπ §◊Õ §≈◊Ëπ‰øøÑ“À—«„®·∫∫ bradycardia (√âÕ¬≈– 23)
·≈â«π”‰ª Ÿà§≈◊Ëπ‰øøÑ“À—«„®·∫∫ asystole (√âÕ¬≈– 22)
à«π§≈◊Ëπ‰øøÑ“À—«„®·∫∫ ventricular fibrillation æ∫ª√–¡“≥
√âÕ¬≈– 14 (√âÕ¬≈– 4.3)3, 20
“‡Àµÿ¢Õß¿“«–À—«„®À¬ÿ¥‡µâπ∑’‰Ë ¡à§“¥§‘¥ °“√«“߬“
√–ß— ∫ §«“¡√Ÿâ ÷ ° ∑ÿ ° ¢—È π µÕπ¡’ ‚ Õ°“ ∑’Ë ® –‡°‘ ¥ ¿“«–À— « „®
À¬ÿ¥‡µâπ‰¥â∑—Èßπ—Èπ Õ“®µ—Èß·µà°“√π” ≈∫ °“√©’¥¬“™“‡©æ“–∑’Ë
°“√∑” regional anesthesia °“√«“߬“ ≈∫ °“√ª≈àÕ¬∑’Ë√—¥
tourniquet °“√„ à∑àՙ૬À“¬„® °“√·∑ßÀ≈Õ¥‡≈◊Õ¥¥”„À≠à
´÷Ëß·¡â«à“„πªí®®ÿ∫—π¬“∑’Ë„™â„π∑“ß«‘ —≠≠’≈â«π·µà‡ªìπ¬“∑’Ë¡’
§«“¡ª≈Õ¥¿—¬¡“°°«à“„πÕ¥’µ ·µàÕ¬à“߉√°Áµ“¡¬“∑ÿ°µ—«
∑’ªË ≈Õ¥¿—¬≈â«π·µà¡√’ “¬ß“π°“√‡°‘¥¿“«–À—«„®À¬ÿ¥‡µâπ∑—ßÈ π—πÈ
´÷Ëß∑—Èßπ’ÈÕ“®‰¡à‰¥â‡ªìπ¿“«–·∑√°´âÕπ®“°¬“ ·µàÕ“®‡°‘¥
À≈“¬ªí®®—¬ ≈—°…≥–ºŸâªÉ«¬∑—Èß∑’Ë∑√“∫·≈–‰¡à∑√“∫¡“°àÕπ
‡∑§π‘§°“√„™â¬“ °“√ºà“µ—¥ ¥—ßπ—Èπ°“√«“߬“√–ß—∫§«“¡√Ÿâ ÷°
ºŸâªÉ«¬∑ÿ°√“¬®÷ß¡’‚Õ°“ ∑’Ë®–‡°‘¥¿“«–À—«„®À¬ÿ¥‡µâπ∑’ˉ¡à
§“¥§‘¥‚¥¬¡’ “‡Àµÿ∑’ËÀ≈“°À≈“¬
“‡Àµÿ¢Õß¿“«–À—«„®À¬ÿ¥‡µâπ∑’ˉ¡à§“¥§‘¥
¡“§¡·æ∑¬å‚√§À—«„®·Ààß À√—∞Õ‡¡√‘°“6, 12 ‰¥â·∫àß
“‡Àµÿ ¢ Õß¿“«–À— « „®À¬ÿ ¥ ‡µâ π ∑—È ß „π‡¥Á ° ·≈–ºŸâ „ À≠à ‡ ªì π
2 “‡ÀµÿÀ≈—° §◊Õ “‡Àµÿ¥â“π√–∫∫À—«„®·≈–À≈Õ¥‡≈◊Õ¥
·≈– “‡Àµÿ∑“ߥâ“π°“√¢“¥ÕÕ°´‘‡®π ‡æ◊ËÕßà“¬µàÕ°“√®¥®”
·≈–¥Ÿ·≈ºŸâªÉ«¬ „πºŸâ„À≠à∑’ˇ°‘¥¿“«–À—«„®À¬ÿ¥‡µâπ¡—°‡°‘¥
®“°¿“«–À—«„®¢“¥‡≈◊Õ¥ ´÷Ëß —¡æ—π∏å°—∫§≈◊Ëπ‰øøÑ“À—«„®·∫∫
ventricular fibrillation ´÷Ëß°“√√—°…“À≈—° §◊Õ °“√™ÁÕ°À—«„®
¥â«¬‰øøÑ“ à«π “‡Àµÿ¥â“π°“√¢“¥ÕÕ°´‘‡®π ‡™àπ √–∫∫
∑“߇¥‘πÀ“¬„®≈⡇À≈« §«“¡¥—π‚≈À‘µµ°∑”„Àâ‡≈◊Õ¥‰ª‡≈’¬È ß
à«πµà“ßÊ ¢Õß√à“ß°“¬‰¡à‡æ’¬ßæÕ ‡ªìπµâπ ‚¥¬¡—°æ∫„π‡¥Á°
ºŸâªÉ«¬∑’ˉ¥â√—∫∫“¥‡®Á∫ ºŸâªÉ«¬‰¥â√—∫¬“‡°‘π¢π“¥ ºŸâªÉ«¬®¡πÈ”
àߺ≈„Àâ√–∫∫À“¬„®≈⡇À≈«À√◊Õ¡’‡≈◊Õ¥‰ª‡≈’È¬ß à«πµà“ßÊ
¢Õß√à “ ß°“¬‰¡à ‡ æ’ ¬ ßæÕ∑”„Àâ Õ «— ¬ «–µà “ ßÊ ¢Õß√à “ ß°“¬
¢“¥ÕÕ°´‘‡®π
”À√— ∫ ß“π¥â “ π«‘ — ≠ ≠’ «‘ ∑ ¬“‰¥â ¡’ ° “√»÷ ° …“ “‡Àµÿ
¢Õß¿“«–À—«„®À¬ÿ¥‡µâπ∑’Ëæ∫„π√–À«à“ßÀ√◊ÕÀ≈—ß°“√«“߬“
√–ß—∫§«“¡√Ÿâ ÷° „πÕ¥’µ “‡Àµÿ à«π„À≠৫“¡¥—π‚≈À‘µµ°
‚¥¬‡©æ“–®“°¬“ ≈∫∑’Ë„™âÀ√◊Õ°“√ Ÿ≠‡ ’¬‡≈◊Õ¥ ·≈–¿“«–
¢“¥ÕÕ°´‘‡®π‡ªìπÀ≈—° ´÷Ëßæ∫¡“°¢÷Èπ„πºŸâ ŸßÕ“¬ÿ ºŸâªÉ«¬∑’Ë¡’
Õ“°“√√ÿπ·√ß ´÷Ëß𔉪 Ÿà°“√æ—≤π“‡∑§π‘§ ¬“™π‘¥µà“ßÊ ·≈–
°“√®—¥µ—ÈßÀâÕßæ—°øóôπ °“√¥Ÿ·≈ºŸâªÉ«¬Õ¬à“ß„°≈♑¥∑’Ëπ“π¢÷Èπ
®“°°“√»÷°…“„πªí®®ÿ∫—πæ∫«à“ “‡ÀµÿÀ≈—°¢Õß¿“«–
À—«„®À¬ÿ¥‡µâπ8, 10, 13-17 §◊Õ §«“¡¥—π‚≈À‘µµ°‚¥¬‡©æ“–®“°°“√
æ√àÕ߇≈◊Õ¥·≈– “√πÈ”®“°°“√‡ ’¬‡≈◊Õ¥¡“°‡ªì𠓇ÀµÿÀ≈—°
∑—Èß„π™à«ß°àÕπºà“µ—¥ ¢≥–ºà“µ—¥ ·≈–™à«ßÀ≈—ßºà“µ—¥ ‚¥¬
216
»√’π§√‘π∑√凫™ “√ 2551; 23(2)
Unexpected Cardiac Arrest and Anesthesia
•
Srinagarind Med J 2008; 23(2)
æ≈æ—π∏å ∫ÿ≠¡“°
•
4. ¿“«–©ÿ°‡©‘π
5. æ∫„π‡æ»™“¬¡“°°«à“‡æ»À≠‘ß
6. πÕ°™à«ß‡«≈“∑”ß“πª°µ‘
7. µ√’ µ—È ß §√√¿å ‚¥¬‡©æ“–‰¥â √— ∫ °“√«“߬“√–ß— ∫
§«“¡√Ÿâ ÷°·∫∫∑—Ë«‰ª
8. °“√„Àâ ∫ √‘ ° “√«‘ — ≠ ≠’ ‚ ¥¬‰¡à ‰ ¥â ‡ ªì π ∫ÿ § ≈“°√∑“ß
«‘ —≠≠’
9. Õ◊ËπÊ ‡™àπ Hematocrit πâÕ¬°«à“ √âÕ¬≈– 30 ¡’ª√–«—µ‘
malignant hyperthermia ‰¥â√—∫¬“ MAOI
¿“«–À— « „®À¬ÿ ¥ ‡µâ π ∑’Ë ‰ ¡à § “¥§‘ ¥ °— ∫ °“√©’ ¥ ¬“™“‡¢â “
‰¢ —πÀ≈—ß
Õÿ ∫— µ‘ ° “√≥å ¢ Õß¿“«–À— « „®À¬ÿ ¥ ‡µâ π °— ∫ °“√„™â ¬ “™“
‡©æ“–∑’Ëæ∫ 1.8 µàÕºŸâªÉ«¬ 10,000 √“¬ ¢≥–∑’ËÕÿ∫—µ‘°“√≥å
¢Õß¿“«–À—«„®À¬ÿ¥‡µâπ„π°“√©’¥¬“™“‡¢â“‰¢ —πÀ≈—ßæ∫ Ÿß
°«à“§◊Õ 2.9 - 3.5 µàÕºŸâªÉ«¬ 10,000 √“¬ 21-23 ¡—°æ∫„πºŸâªÉ«¬
∑’Ë¡’ ASA physical status µË” ·≈–¡—°æ∫·∫∫‰¡à§“¥§‘¥
´÷ßË ‡°‘¥®“° “‡Àµÿ¢Õß√–∫∫À“¬„®≈⡇À≈«∑”„À⢓¥ÕÕ°´‘‡®π
∂÷ß√âÕ¬≈– 50 24 ‡™àπ total spinal block ‡ªìπµâπ πÕ°®“°π’Ȭ—ß
‡°‘¥®“°¿“«– bradycardia 25 ∑’ˇ°‘¥®“° high spinal block À√◊Õ
®“° Bezold Jarisch Reflex À√◊ÕÕ“®‡°‘¥¿“«–¬“™“‡ªìπæ‘…
¿“«–À— « „®À¬ÿ ¥ ‡µâ π ®– — ¡ æ— π ∏å °— ∫ °“√‡°‘ ¥ §«“¡¥— π
‚≈À‘µµ°·≈–À—«„®‡µâπ™â“µË”°«à“ 60 §√—ÈßµàÕπ“∑’ ´÷Ëߧ«“¡
¥—π‚≈À‘µµ°æ∫ª√–¡“≥√âÕ¬≈– 36.8 ‚¥¬æ∫¡“°¢÷Èπ„π
ºŸâªÉ«¬ ŸßÕ“¬ÿ °“√ºà“µ—¥§≈Õ¥ °“√„Àâ “√πÈ”°àÕπ©’¥¬“™“
πâÕ¬°«à“ 500 ¡≈. √–¥—∫°“√™“ Ÿß°«à“ T4 BMI ¡“°°«à“ 30 26, 27
à«πÀ—«„®‡µâπ™â“µË”°«à“ 60 §√—ÈßµàÕπ“∑’ æ∫√âÕ¬≈– 4.9 - 10.2
∂⓵˔°«à“ 40 §√—ÈßµàÕπ“∑’ æ∫√âÕ¬≈– 0.7 ‚¥¬æ∫¡“°¢÷Èπ
‡¡◊ËÕ√–¥—∫°“√™“ Ÿß°«à“ T4 ‡æ»™“¬ Õ—µ√“°“√‡µâπ¢Õß
À— « „®µË” ¿“«– first degree AV block à « πÕ“¬ÿ π—È π
∫“ß°“√»÷°…“æ∫«à“Õ“¬ÿπÕâ ¬‡ªìπªí®®—¬‡ ¬’Ë ß26 ∫“ß°“√»÷°…“
æ∫«à“ Õ“¬ÿ¡“°‡ªìπªí®®—¬‡ ’ˬß27
πÕ°®“°π’Ȭ—ß —¡æ—π∏å°—∫°“√¥Ÿ·≈√—°…“¿“«–·∑√°´âÕπ
‰¡à‡À¡“– ¡À√◊ՙⓇ°‘π‰ª °“√≈–‡≈¬º≈¢Õ߬“Õ◊ËπÊ ∑’Ë„™â
√à « ¡°— ∫ °“√©’ ¥ ¬“™“‡¢â “ ‰¢ — π À≈— ß28, 29 ºŸâ ªÉ « ¬∑’Ë ‰ ¥â √— ∫ ¬“
πÕπÀ≈—∫Õ◊Ëπ√à«¡¥â«¬3 ¿“«–©ÿ°‡©‘π ·≈–°“√„™â¬“ tetracaine
°“√ªÑÕß°—π°“√‡°‘¥¿“«–À—«„®À¬ÿ¥‡µâπ
°“√ªÑÕß°—π°“√‡°‘¥¿“«–À—«„®À¬ÿ¥‡µâπ‰¥â∫√√®ÿ‰«â„π
¡“µ√∞“π°“√«“߬“√–ß—∫§«“¡√Ÿâ ÷° °“√∑’Ë¡’∫ÿ§≈“°√∑’Ë¡’
§«“¡ “¡“√∂∑’Ë„Àâ°“√¥Ÿ·≈µ“¡¡“µ√∞“π ·≈–°“√¡’Õÿª°√≥å
‡ΩÑ“√–«—ß∑’ˇÀ¡“– ¡ °Á®– “¡“√∂™à«¬≈¥Õÿ∫—µ‘°“√≥å„π à«π
¢Õß«‘ —≠≠’≈߉¥â πÕ°®“°π’È„π à«π∑’ˇ°’ˬ«¢âÕß°—∫«‘ —≠≠’
¬— ß “¡“√∂ªÑ Õ ß°— π ‰¥â ‚ ¥¬°“√≈¥§«“¡‡ ’Ë ¬ ߢÕߺŸâ ªÉ « ¬
°“√‡≈◊Õ°„™â¬“∑’Ë¡’ª√– ‘∑∏‘¿“æ
°“√∑’Ë ¡’ ∫ÿ § ≈“°√∑’Ë ¡’ § «“¡ “¡“√∂∑’Ë „ Àâ ° “√¥Ÿ · ≈
µ“¡¡“µ√∞“π ∫ÿ § ≈“°√§«√¡’ § «“¡√Ÿâ §«“¡‡¢â “ „®„π
¡“µ√∞“π°“√ª√–‡¡‘πºŸâªÉ«¬∑—Èß°“√´—°ª√–«—µ‘ µ√«®√à“ß°“¬
·≈–µ√«®∑“ßÀâÕߪؑ∫—µ‘°“√µ“¡§«“¡®”‡ªìπ32 ‡π◊ËÕß®“°
¿“«–À— « „®À¬ÿ ¥ ‡µâ π ∫“ߧ√—È ß ‡°‘ ¥ ®“°°“√‰¡à ª √–‡¡‘ π À√◊ Õ
ª√–‡¡‘πºŸâªÉ«¬‰¡à¥’∑”„À≡à∑√“∫‚√§∑’˺ŸâªÉ«¬‡ªì𠬓∑’Ë·æâ
√à“ß°“¬∑’Ë¡’§«“¡º‘¥ª°µ‘ πÕ°®“°π’È∫ÿ§≈“°√§«√ªØ‘∫—µ‘ß“π
µ“¡¡“µ√∞“π°“√¥Ÿ · ≈°“√«“߬“√–ß— ∫ §«“¡√Ÿâ ÷ ° ∑—È ß ·∫∫
general anesthesia ·≈– regional anesthesia √«¡∑—Èß°“√
monitored anesthesia care33 ´÷Ëß®–™à«¬„Àâ¡’§«“¡ª≈Õ¥¿—¬
¡“°¢÷Èπ
∫ÿ§≈“°√§«√µ√–Àπ—°‡¡◊ËÕ¥Ÿ·≈ºŸâªÉ«¬°≈ÿà¡∑’Ë¡’§«“¡‡ ’ˬß
‡™à𠇥Á°·√°‡°‘¥ ºŸâ ŸßÕ“¬ÿ ºŸâ∑’Ë¡’‚√§ª√–®”µ—« ‡ªìπµâπ ‚¥¬
µâÕß¡’§«“¡„ à„® ‰¡à≈–‡≈¬ µàÕ¿“«–µà“ßÊ ∑’ˇ°‘¥¢÷Èπ ·≈–
¡’§«“¡√Ÿâ∑’ˇ°’ˬ«¢âÕß°—∫°“√¥Ÿ·≈¿“«–µà“ßÊ ∑’ËÕ“®π”‰ª Ÿà
¿“«–À—«„®À¬ÿ¥‡µâ𠇙àπ °“√‡ ’¬‡≈◊Õ¥ °“√„ à∑àՙ૬À“¬„®
‰¡à‰¥â ‡ªìπµâπ ‚¥¬µâÕß¡’°“√µ—¥ ‘π„®∑’ˇÀ¡“– ¡ ‡™àπ °“√∑’Ë¡’
§«“¡¥—π‚≈À‘µµ°À√◊ÕÀ—«„®‡µâπ™â“®“° spinal block §«√„Àâ
°“√√—°…“∑—π∑’ ‡ªìπµâπ ∫“ß°“√»÷°…“æ∫«à“°“√¡’«‘ —≠≠’
·æ∑¬åÀ√◊Õ«‘ —≠≠’·æ∑¬å‡©æ“–∑“ß®–™à«¬„À⇰‘¥Õÿ∫—µ‘°“√≥å
πâÕ¬≈ß·≈–∑”„À⺟âªÉ«¬¡’Õ—µ√“√Õ¥™’«‘µ Ÿß¢÷Èπ34 πÕ°®“°π’È
§«“¡√Ÿâ∑’Ë∑—π¬ÿ§®–™à«¬≈¥Õÿ∫—µ‘°“√≥å≈ß ‡™àπ °“√„™â goal
directed therapy ‡ªìπµâπ
§«“¡√Ÿâ·≈–∑—°…–¢Õß°“√∑” BLS (basic life support),
ACLS (advanced cardiac life support), PALS (pediatric advanced
ªí®®—¬‡ ’ˬߢÕß°“√‡°‘¥¿“«–À—«„®À¬ÿ¥‡µâπ
‡ªìπ∑’Ë∑√“∫¥’«à“ºŸâªÉ«¬∑ÿ°√“¬∑’Ë¡“√—∫°“√«“߬“√–ß—∫
§«“¡√Ÿâ ÷°¡’‚Õ°“ ∑’ˇ°‘¥¿“«–À—«„®À¬ÿ¥‡µâπ ¥—ßπ—Èπ¡“µ√∞“π
°“√¥Ÿ · ≈ºŸâ ªÉ « ¬®÷ ß µâ Õ ß Ÿ ß ·≈–¡’ ° “√‡ΩÑ “ √–«— ß Õ¬à “ ß„°≈â ™‘ ¥
‚¥¬„™â∫ÿ§≈“°√∑“ß«‘ —≠≠’·≈–Õÿª°√≥å™à«¬‡ΩÑ“√–«—ß ·µà
Õ¬à“߉√°Áµ“¡ „πºŸâªÉ«¬∫“ß√“¬æ∫«à“¡’§«“¡‡ ’ˬߡ“°°«à“
ª°µ‘ ´÷ßË π‘¬¡ª√–‡¡‘πºŸªâ «É ¬µ“¡ ASA physical status πÕ°®“°
π’Ȭ—ß¡’°“√»÷°…“À≈“¬°“√»÷°…“∑’Ë欓¬“¡√–∫ÿªí®®—¬‡ ’ˬß
‡æ◊ÕË π”‰ª °Ÿà “√«“ß·ºπ„π°“√ªÑÕß°—π¿“«–À—«„®À¬ÿ¥‡µâπ17, 30-31
‡™àπ
1. §«“¡√ÿπ·√ߢÕß‚√§ Ÿß À√◊Õ ASA physical status
¡“°°«à“ III
2. Õ“¬ÿπâÕ¬À√◊Õ¡“° ‡™à𠇥Á°·√°‡°‘¥ ∑“√° ºŸâ ŸßÕ“¬ÿ
‚¥¬‡©æ“–¡“°°«à“ 84 ªï
3. ‚√§µà“ßÊ ‡™àπ ‚√§À—«„®·µà°”‡π‘¥ morbid obese
°“√µ‘¥‡™◊ÈÕ„π√–∫∫∑“߇¥‘πÀ“¬„® à«π∫π„π‡¥Á°
»√’π§√‘π∑√凫™ “√ 2551; 23(2)
Polpun Boonmak
•
Srinagarind Med J 2008; 23(2)
217
¿“«–À—«„®À¬ÿ¥‡µâπ∑’ˉ¡à§“¥§‘¥·≈–«‘ ≠
— ≠’«‘∑¬“
•
life support)6, 12, 17 ®–™à«¬ªÑÕß°—πÕÿ∫—µ‘°“√≥å ·≈–™à«¬≈¥
°“√‡ ’¬™’«‘µ≈߉¥â®“°°“√¥Ÿ·≈∑’ˇÀ¡“– ¡ ‚¥¬∑—Ë«‰ªæ∫«à“
¿“¬À≈—ß°“√Ωñ°Õ∫√¡ §«“¡√Ÿâ®–§àÕ¬Ê ≈¥≈ß ´÷Ëß®”‡ªìπµâÕß
∑∫∑«πÕ¬Ÿà‡ªìπ√–¬–Ê „π∫“ß°“√»÷°…“§«“¡√ŸâÕ“®Õ¬Ÿà‡æ’¬ß
6-12 ‡¥◊Õπ35
°“√¡’Õÿª°√≥å‡ΩÑ“√–«—ß∑’ˇÀ¡“– ¡ °“√¡’Õÿª°√≥å
°“√‡ΩÑ“√–«—ß∑’ˇÀ¡“– ¡ ®–™à«¬„Àâ “¡“√∂«‘π‘®©—¬ªí≠À“
‰¥â‡√Á«¢÷πÈ ´÷ßË ®–≈¥º≈·∑√°´âÕπ≈߉¥â ‚¥¬æ∫«à“ °“√„™â‡§√◊ÕË ß
pulse oximeter “¡“√∂™à«¬ªÑÕß°—πÕÿ∫µ— °‘ “√≥å‚¥¬‡©æ“–°√≥’
∑’Ë ‡ °‘ ¥ ®“°¿“«–¢“¥ÕÕ°´‘ ‡ ®π36 à«π‡§√◊ËÕß capnogram
°Á “¡“√∂™à«¬ªÑÕß°—πÕÿ∫—µ‘°“√≥å„π°√≥’∑’ˇ°‘¥®“°¿“«–¢“¥
ÕÕ°´‘‡®π ·≈–°“√ºà“µ—¥ ¡Õß34, 36 à«π‡§√◊ËÕß«—¥ bispectral
index °Á “¡“√∂™à«¬≈¥°“√„À⬓ ≈∫‡°‘𧫓¡®”‡ªìπ
°“√≈¥§«“¡‡ ’Ë ¬ ߢÕߺŸâ ªÉ « ¬ °“√„™â¬“°≈ÿà¡ beta
blocker „π√“¬∑’¡Ë ¢’ Õâ ∫àß™’„È π°“√„™â “¡“√∂≈¥¿“«–·∑√°´âÕπ
∑“ß√–∫∫‰À≈‡«’¬π‚≈À‘µ √«¡∑—Èß≈¥Õ—µ√“°“√‡ ’¬™’«‘µ„π
√–¬–¬“«37 À√◊Õ °“√ºà“µ—¥‡¡◊ÕË ºŸªâ «É ¬¡’§«“¡æ√âÕ¡∑’Ë ¥ÿ ‡ªìπµâπ
°“√‡≈◊Õ°„™â¬“∑’¡Ë ª’ √– ∑‘ ∏‘¿“æ ¬“∑’„Ë ™â„π∑“ß«‘ ≠
— ≠’
∑ÿ°«—ππ’ȇ°◊Õ∫∑—ÈßÀ¡¥∂◊Õ«à“‡ªìπ¬“∑’Ë¡’§«“¡ª≈Õ¥¿—¬ Ÿß ‡¡◊ËÕ
¡’„™âÕ¬à“ß√–¡—¥√–«—ß ·≈–¡’°“√¥Ÿ·≈¢≥–„™â¬“Õ¬à“ß„°≈♑¥
·µàª≠
í À“∑’æË ∫ §◊Õ °“√‰¡à√–¡—¥√–«—ß°“√„™â °“√„À⬓º‘¥¢π“¥
º‘¥§π º‘¥¬“ ´÷ËßµâÕß¡’ °“√ªÑÕß°—πÕ¬à“ß√Õ∫§Õ∫
√–∫∫ß“π·≈– ‘Ëß·«¥≈âÕ¡∑’Ë¥’ √–∫∫ß“π∑’Ë¥’¡’°“√
ª√–‡¡‘πºŸâªÉ«¬°àÕπºà“µ—¥ ¡’°“√∑”ß“π‡ªìπ∑’¡·∫∫ À “¢“
∑’Ë Õ¥§≈â Õ ß°— π √«¡∑—È ß °“√¡’ Àâ Õ ßæ— ° øóô π ∑’Ë ¥Ÿ · ≈ºŸâ ªÉ « ¬
Õ¬à “ ß„°≈â ™‘ ¥ ≈â « π·µà ™à « ¬„Àâ ‡ °‘ ¥ Õÿ ∫— µ‘ ° “√≥å ≈ ¥πâ Õ ¬≈ß
¿“æ·«¥≈âÕ¡„π∑’Ë∑”ß“π∑’Ë¥’ ¡’°“√∑”ß“π‡ªìπ∑’¡ “¡—§§’
¡’ § «“¡æ÷ ß æÕ„®µà Õ ß“π Ÿ ß ®–™à « ¬„Àâ ª √– ‘ ∑ ∏‘ ¿ “æ¢Õß
∫ÿ § ≈“°√¥’ ¢÷È π à ß º≈≈¥°“√‡°‘ ¥ ¿“«–·∑√°´â Õ π √«¡∑—È ß
°“√°”Àπ¥√–¬–‡«≈“∑”ß“π∑’Ë ‡ À¡“– ¡ ‰¡à ∑”„Àâ ‡ °‘ ¥
§«“¡‡Àπ◊Ë Õ ¬≈â “ ‡°‘ 𠉪 38 ´÷Ëߧ«“¡‡Àπ◊ËÕ¬≈â“¡—°π”‰ª Ÿà
§«“¡º‘¥æ≈“¥¢Õ߇®â“Àπâ“∑’∫Ë “ß°“√»÷°…“æ∫«à“§«“¡º‘¥æ≈“¥
‡ªì𠓇ÀµÿÀπ÷Ëß∑’Ë ”§—≠¢Õß°“√‡°‘¥¿“«–À—«„®À¬ÿ¥‡µâπ9
πÕ°®“°π’È°“√®—¥°“√∑’˙૬≈¥¿“«–À—«„®À¬ÿ¥‡µâ𠇙àπ
°“√¥Ÿ·≈ºŸâªÉ«¬∑’˵âÕß„À⬓√–ß—∫§«“¡√Ÿâ ÷°‚¥¬«‘ —≠≠’ °“√®—¥
§«“¡æ√âÕ¡¢Õß ∂“π∑’Ë„π°“√√—∫Õÿ∫—µ‘°“√≥å °“√®—¥®”π«π
∫ÿ § ≈“°√„Àâ ‡ À¡“– ¡‚¥¬‡©æ“–°√≥’ ∑’Ë ¡’ ¿ “«–©ÿ ° ‡©‘ π39
‡ªìπµâπ ‚¥¬∑’ÀË ≈“¬°“√»÷°…“æ∫«à“™à«ßπÕ°‡«≈“∑”ß“πª°µ‘
‡ªìπ™à«ß∑’Ë¡’§«“¡‡ ’ˬߵàÕ¿“«–À—«„®À¬ÿ¥‡µâπ38 ·≈–ºŸâªÉ«¬
®–¡’‚Õ°“ √Õ¥™’«‘µπâÕ¬≈ß„π™à«ß¥—ß°≈à“«
218
»√’π§√‘π∑√凫™ “√ 2551; 23(2)
Unexpected Cardiac Arrest and Anesthesia
°“√¥Ÿ · ≈ºŸâ ªÉ « ¬ ‡¡◊Ë Õ ‡°‘ ¥ ¿“«–À— « „®À¬ÿ ¥ ‡µâ π ∑’Ë ‰ ¡à
§“¥§‘¥ 3, 6, 17, 40
1. ªÑÕß°—π‚¥¬¥Ÿ·≈ºŸâªÉ«¬Õ¬à“ß√Õ∫§Õ∫ „ à„®µàÕ
≠
— ≠“≥‡µ◊Õπµà“ßÊ §≈◊πË ‰øøÑ“À—«„®À“¬‰ª °“√«—¥§«“¡¥—π
‚≈À‘µ‰¡à‰¥â §≈◊Ëπ¢Õߧ“√å∫Õπ‰¥ÕÕ°‰´¥å∑’ËÀ“¬‰ª §≈◊Ëπ¢Õß
‡§√◊ÕË ß«—¥§«“¡Õ‘¡Ë µ—«¢ÕßÕÕ°´‘‡®π∑’ÀË “¬‰ª ‡ΩÑ“¥ŸºªâŸ «É ¬µ≈Õ¥
¥Ÿ‡≈◊Õ¥ ∑’ §’Ë ≈È”≈ß ‡¢’¬« À¡¥ µ‘ Õ“°“√§≈◊πË ‰ Õâ “‡®’¬π À“¬„®
‰¡àÕ‘Ë¡ ‡Àµÿ°“√≥å‡À≈à“π’ÈÕ“®π”¡“´÷Ëß¿“«–À—«„®À¬ÿ¥‡µâπ‰¥â
2. «‘π®‘ ©—¬¿“«–À—«„®À¬ÿ¥‡µâπ °“√«‘π®‘ ©—¬¿“«–À—«„®
À¬ÿ¥‡µâπ∑”‚¥¬°“√§≈”™’æ®√∑’Ë carotid artery, femoral artery
À√◊Õ brachial artery („π‡¥Á°) À√◊Õ ¡’§«“¡¥—π‚≈À‘µµË”‡°‘π°«à“
®–¡’‡≈◊Õ¥‰ª‡≈’È¬ß ¡Õ߇撬ßæÕ ´÷Ëߧ≈◊Ëπ‰øøÑ“À—«„®Õ“®‡ªìπ
≈—°…≥–„¥°Á‰¥â Õ“®‡ªìπ ventricular fibrillation, asystole, bradycardia, tachycardia À√◊Õ normal sinus rhythm °Á‰¥â6 §«“¡
º‘¥æ≈“¥∑’ËÕ“®æ∫ §◊Õ „πºŸâ„À≠à‡¡◊ËÕ¡’¿“«– pulseless
electrical activity (PEA) À√◊Õ„π‡¥Á°∑’¡Ë À’ «— „®‡µâπ™â“°«à“ 60 §√—ßÈ
µàÕπ“∑’·≈–¡’‡≈◊Õ¥‰ª‡≈’Ȭß√à“ß°“¬‰¡àæÕ·≈⫉¡à∑”°“√°¥
Àπâ“Õ°∑”„À⥟·≈ºŸâªÉ«¬‰¥â≈à“™â“
3. µ—Èß µ‘ „®‡¬Áπ ∑∫∑«π ‘Ëß∑’ˇ°‘¥¢÷Èπ ∑∫∑«π§«“¡√Ÿâ
·≈–∑—°…–∑’Ë¡’ ‡æ◊ËÕ¥Ÿ·≈ºŸâªÉ«¬„À⥒∑’Ë ÿ¥ °“√∑’ËÀ“ “‡Àµÿ‰¥â‡√Á«
®–™à«¬„À⥟·≈ºŸâªÉ«¬‰¥â¥’¢÷Èπ
4. ·®â߇æ◊ËÕπ√à«¡ß“π‡æ◊ËÕ„Àâ∑√“∫‚¥¬∑—Ë«°—π ∑—Èß·æ∑¬å
‡®â“¢Õ߉¢âÀ√◊Õ»—≈¬·æ∑¬å ∑’¡æ¬“∫“≈ à߇§√◊ËÕß¡◊Õ ·≈–
‡®â“Àπâ“∑’ËÕ◊ËπÊ ‡°’ˬ«¢âÕß ‡æ◊ËÕ„Àâ∑√“∫ ∂“π°“√≥å∑’ˇ°‘¥¢÷Èπ
·≈–¢Õ§«“¡™à«¬‡À≈◊Õ∑’˵âÕß°“√ ‡™àπ Õ“®À¬ÿ¥ºà“µ—¥ À√◊Õ
Õ“®„Àâ™à«¬À¬ÿ¥°“√‡ ’¬‡≈◊Õ¥ ‡ªìπµâπ
5. ªî¥¬“ ≈∫·≈–¬“∑ÿ°™π‘¥∑’ˉ¡à®”‡ªìπ ‚¥¬‡©æ“–
¬“∑’ËÕ“®°√–µÿâπ„À⺟âªÉ«¬·¬à≈ß
6. ª√–‡¡‘π∑“߇¥‘πÀ“¬„® ‡ªî¥∑“߇¥‘πÀ“¬„®·≈–
™à«¬À“¬„® ‚¥¬„ÀâÕÕ°´‘‡®π 100 ‡ªÕ√凴Áπµå·°àºŸâªÉ«¬∑ÿ°√“¬
·≈–™à«¬À“¬„®ºà“π∑“ßÀπâ“°“° À√◊Õ∑àՙ૬À“¬„® «à π°√≥’
„ à∑àՙ૬À“¬„®·≈⫧«√µ√«® Õ∫µ”·Àπàß«à“‡À¡“– ¡
À√◊Õ‰¡à‚¥¬°“√¥Ÿ øíßÀ√◊Õ„™âÕÿª°√≥å™à«¬ „π°√≥’∑’ˉ¡à “¡“√∂
™à«¬À“¬„®À√◊Õ„ à∑àՙ૬À“¬„®‰¥âÕ“®æ‘®“√≥“„™âÕÿª°√≥å
Õ◊ËπÊ ™à«¬ ‡™àπ LMA, cricothyroidotomy ‡ªìπµâπ
7. °“√™à « ¬À“¬„®„πºŸâ ªÉ « ¬∑’Ë ¡’ ¿ “«–À— « „®À¬ÿ ¥ ‡µâ π
ª√‘¡“≥≈¡®–≈¥≈ß®“°ª°µ‘§◊Õ 6-7 ¡≈. µàÕ °°. À√◊ՙ૬
À“¬„®®πÀπâ“Õ°¢¬“¬ ‡π◊ËÕß®“°ª√‘¡“≥‡≈◊Õ¥‰ª¬—ßÀ—«„®¡’
πâÕ¬°«à“ºŸâªÉ«¬ª°µ‘ ·≈–™à«¬À“¬„®·§à 8-10 §√—ÈßµàÕπ“∑’
°“√™à«¬À“¬„®¡“°‡°‘π‰ª∑”„Àâª√‘¡“≥‡≈◊Õ¥°≈—∫ ŸàÀ—«„®
πâÕ¬≈ß
•
Srinagarind Med J 2008; 23(2)
æ≈æ—π∏å ∫ÿ≠¡“°
•
8. °“√°¥Àπâ“Õ°§«√∑”∑—π∑’‡¡◊ËÕ‰¡à¡’™’æ®√„πÕ—µ√“
100 §√—Èß µàÕπ“∑’ ‚¥¬§«√°¥≈÷° 1.5-2 π‘È«„πºŸâ„À≠à °√≥’∑’Ë
‰¡à‰¥â„ à∑àՙ૬À“¬„®§«√°¥„πÕ—µ√“ 30 µàÕ 2 ¬°‡«âπ„π
‡¥Á°∑’¡Ë ∫’ §ÿ ≈“°√∑“ß°“√·æ∑¬å 2 §π®–„™âÕµ— √“ 15 µàÕ 2 «à π
°√≥’ ∑’Ë „ à ∑à Õ ™à « ¬À“¬„®·≈â « §«√∑”°“√°¥Àπâ “ Õ°·≈–
™à«¬À“¬„®‚¥¬‰¡à —¡æ—π∏å°—π À≈—°°“√ ”§—≠§◊Õ§«“¡≈â“
∑”„Àâª√– ∑‘ ∏‘¿“æ¢Õß°“√°¥Àπâ“Õ°≈¥≈ß ¥—ßπ—πÈ µâÕ߇ª≈’¬Ë π
§π„À¡à¡“°¥Àπâ“Õ°∑ÿ° 2 π“∑’
9. Õà“π§≈◊Ëπ‰øøÑ“À—«„®«à“ “¡“√∂√—°…“‚¥¬°“√™ÁÕ°
¥â«¬‰øøÑ“‰¥âÀ√◊Õ‰¡à ´÷ßË ∑”„Àâ “¡“√∂·¬°‰¥â«“à §«√„™â·π«∑“ß
„¥√–À«à“ß·π«∑“ß ventricular fibrillation/pulseless ventricular
tachycardia À√◊Õ·π«∑“ß asystole/PEA °√≥’∑’ˇªìπ ventricular
fibrillation ·≈– pulseless ventricular tachycardia æ‘®“√≥“
™ÁÕ°¥â«¬‰øøÑ“„Àâ‡√Á«∑’Ë ÿ¥Àπ÷Ëߧ√—Èß ¥â«¬°”≈—ß 120-200 ®Ÿ≈
(biphasic) À√◊Õ 360 ®Ÿ≈ (monophasic)
10. À¬ÿ¥°¥Àπâ“Õ°„ÀâπÕâ ¬∑’Ë ¥ÿ ‡∑à“∑’‡Ë ªìπ‰ª‰¥â ‡π◊ÕË ß®“°
®–≈¥ª√‘¡“≥‡≈◊Õ¥‰ª‡≈’Ȭß√à“ß°“¬ ‚¥¬Õ“®À¬ÿ¥°¥™—Ë«§√“«
°√≥’∑’˧≈”™’æ®√ (‡¡◊ËÕ‰¡à¡’‡§√◊ËÕßµ√«®§≈◊Ëπ‰øøÑ“À—«„® À√◊Õ
§≈◊Ëπ‰øøÑ“À—«„®‡ªìπ™π‘¥∑’Ëπà“®–¡’™’æ®√) Õ¥∑àՙ૬À“¬„®
‡¢â“À≈Õ¥§Õ ‡§≈◊ËÕπ¬â“¬ºŸâªÉ«¬·≈–™ÁÕ°À—«„®¥â«¬‰øøÑ“
11. ºŸâªÉ«¬∑’Ë¡’¿“«– asystole/PEA µâÕß欓¬“¡À“ “‡Àµÿ
¢Õß¿“«–À—«„®À¬ÿ¥‡µâπ∑’Ë·°â‰¢‰¥â·≈–‡ªìπ‰ª‰¥â¡“°∑’Ë ÿ¥
·≈â«·°â‰¢ ´÷Ëß “‡Àµÿ∑’ˇªìπ‰ª‰¥â Õ“®®”‰¥âßà“¬Ê §◊Õ 6H 6T
䴉ᡈ
11.1 6H
11.1.1 hypoxia
11.1.2 hypovolemia
11.1.3 hypothermia
11.1.4 hypoglycemia
11.1.5 hypo/hyperkalemia
11.2 6T
11.2.1 tension pneumothorax
11.2.2 cardiac tamponade
11.2.3 thrombosis myocardial ischemia
11.2.4 thrombosis pulmonary embolism
11.2.5 trauma (hypoxia, hypovolemia, severe
brain injury)
12. „À⬓√—°…“µ“¡¢âÕ∫àß™’È ‚¥¬‰¡à„™â¬“¡“°À√◊ÕπâÕ¬
‡°‘π‰ª ´÷Ëß®–∑”„À⇰‘¥º≈‡ ’¬
12.1 °≈ÿà¡ vasopressor
12.1.1 epinephrine „™â ”À√—∫ºŸªâ «É ¬∑’¡Ë ¿’ “«–
À—«„®À¬ÿ¥‡µâπ∑—Èß 2 °√≥’ ¢π“¥¬“ 1 ¡°.∑“ßÀ≈Õ¥‡≈◊Õ¥¥”
À√◊ Õ intraosseous ∑ÿ ° 3-5 π“∑’ (class IIb) ·≈–∑“ß
»√’π§√‘π∑√凫™ “√ 2551; 23(2)
Polpun Boonmak
∑àՙ૬À“¬„® 2-2.5 ¡°. ¬“¢π“¥ Ÿß„™â°√≥’‰¥â√—∫¬“ beta
blocker ·≈– Ca channel blocker ‡°‘π¢π“¥
12.1.2 vasopressin „™â ”À√— ∫ ºŸâ ªÉ « ¬∑’Ë ¡’
¿“«–À—«„®À¬ÿ¥‡µâπ∑—Èß 2 °√≥’ ¢π“¥¬“ 40 ¬Ÿπ‘µ ∑“ß
À≈Õ¥‡≈◊Õ¥¥”À√◊Õ intraosseous §√—È߇¥’¬«
12.1.3 atropine „™â ”À√—∫ºŸâªÉ«¬∑’Ë¡’¿“«–
slow PEA À√◊Õ asystole ¢π“¥¬“ 1 ¡°.∑“ßÀ≈Õ¥‡≈◊Õ¥¥”
À√◊Õ intraosseous ∑ÿ° 3-5 π“∑’ √«¡‰¡à‡°‘π 3 ¡°. (¢π“¥¬“
0.5 ¡°. „™â ”À√—∫¿“«– bradycardia)
12.2 °≈ÿà¡ antiarrhythmic
12.2.1 amiodarone „™â ”À√—∫ºŸªâ «É ¬∑’¡Ë ¿’ “«–
VF/pulseless VT (class IIb) ∑’Ë≈⡇À≈«®“°°“√™ÁÕ°¥â«¬‰øøÑ“
À√◊ Õ epinephrine, vasopressin ¢π“¥¬“ 300 ¡°.∑“ß
À≈Õ¥‡≈◊Õ¥¥”À√◊Õ intraosseous Õ“®„Àâ´È”‰¥âÕ’° 150 ¡°.
12.2.2 lidocaine „™â ”À√—∫ºŸªâ «É ¬∑’¡Ë ¿’ “«– VF/
pulseless VT (class indeterminate) ∑’Ë≈⡇À≈«®“°°“√™ÁÕ°¥â«¬
‰øøÑ“À√◊Õ epinephrine, vasopressin ¢π“¥¬“ 1-1.5 ¡°.µàÕ°°.
∑“ßÀ≈Õ¥‡≈◊Õ¥¥”À√◊Õ intraosseous “¡“√∂„Àâ´È”‰¥â 0.5-0.75
¡°.µàÕ°°.∑ÿ° 5-10 π“∑’Õ’° 2 §√—Èß √«¡‰¡à‡°‘π 3 ¡°.µàÕ°°.
12.2.3 magnesium sulfate „™â ”À√—∫ºŸâªÉ«¬
∑’Ë¡’§≈◊Ëπ‰øøÑ“À—«„® Torsades de Pointes (irregular/polymorphic
VT with QT prolong) ¢π“¥¬“ 1-2 °. ∑“ßÀ≈Õ¥‡≈◊Õ¥¥”
„π‡«≈“ 5-20 π“∑’ ° √≥’ ∑’Ë ‰ ¡à ¡’ ™’ æ ®√ ·≈– 1-2 °. ∑“ß
À≈Õ¥‡≈◊Õ¥¥”„π‡«≈“ 5-60 π“∑’°√≥’∑’Ë¡’™’æ®√
12.3 ¬“°≈ÿà¡Õ◊Ëπ Ê
12.3.1 NaHCO 3 §«√„Àâ ‡ ¡◊Ë Õ ¿“«–À— « „®
À¬ÿ¥‡µâπ —¡æ—π∏å°—∫ metabolic acidosis, hyperkalemia,
tricyclic antidepressant À√◊ՙ૬°Ÿâ™’æ¡“π“π à«π„π¿“«–
respiratory acidosis ¡’ hypercarbia ∑’ˉ¡à‰¥â„ à∑àՙ૬À“¬„®
À√◊ՙ૬À“¬„®‰¡à‰¥â ∂◊Õ‡ªìπ¢âÕÀâ“¡„™â
13. √–À«à“ߙ૬°Ÿâ™’槫√ª√–‡¡‘πºŸâªÉ«¬´È”‡ªìπ√–¬–Ê
‡æ◊ËÕ·°â‰¢ªí≠À“∑’ËÕ“®‡°‘¥¢≥–π—È𠇙àπ ∑àՙ૬À“¬„®À≈ÿ¥
´’Ë‚§√ßÀ—° ‡ªìπµâπ ‚¥¬Õ“®„™âÕÿª°√≥å‡ΩÑ“√–«—ߙ૬„π°“√
¥Ÿ·≈ºŸâªÉ«¬ ‡™àπ °“√„™â‡§√◊ËÕß«—¥§“√å∫Õπ‰¥ÕÕ°‰´¥å„π
≈¡À“¬„®ÕÕ°®–™à « ¬∫Õ°‚Õ°“ √Õ¥™’ «‘ µ (§à “ ¡“°°«à “
10 ¡¡.ª√Õ∑), invasive blood pressure ‡ªìπµâπ
14. °”Àπ¥Àπâ“∑’Ë„π°“√¥Ÿ·≈ºŸâªÉ«¬„Àâ™—¥‡®π ‚¥¬‡©æ“–
ºŸâπ”∑’¡ ºŸâ¥Ÿ·≈∑“߇¥‘πÀ“¬„® ºŸâ°¥Àπâ“Õ° ºŸâ„À⬓·≈–
‡µ√’¬¡‡§√◊ËÕß™ÁÕ°À—«„®¥â«¬‰øøÑ“ ºŸâ∫—π∑÷° ´÷Ëߧ«√µâÕß¡’°“√
°”Àπ¥≈à«ßÀπ⓵“¡§«“¡‡À¡“– ¡¢Õß·µà≈–‚√ß欓∫“≈
15. ·®âß¢à“«·°à≠“µ‘·≈–ºŸâ‡°’ˬ«¢âÕß‚¥¬‡√‘Ë¡„Àâ¢âÕ¡Ÿ≈
µ—Èß·µà‡√‘Ë¡¡’Õÿ∫—µ‘°“√≥å
16. ‡¡◊ÕË ºŸªâ «É ¬°≈—∫¡“¡’ ≠
— ≠“≥™’æµâÕߥŸ·≈Õ¬à“ß„°≈♥‘
•
Srinagarind Med J 2008; 23(2)
219
¿“«–À—«„®À¬ÿ¥‡µâπ∑’ˉ¡à§“¥§‘¥·≈–«‘ ≠
— ≠’«‘∑¬“
•
Unexpected Cardiac Arrest and Anesthesia
ventricular fibrillation §«√√—°…“Õÿ≥À¿Ÿ¡‘°“¬µË” (therapeutic
hypothermia) 32-34 Õß»“‡´≈‡´’¬ π“π 12-24 ™—Ë«‚¡ß
17. ¿“¬À≈—ß°“√¥Ÿ·≈ºŸâªÉ«¬‡√’¬∫√âÕ¬µâÕßπ”¢âÕ¡Ÿ≈∑’Ë¡’
‡Àµÿ°“√≥å∑’ˇ°‘¥¢÷Èπ ªí≠À“∑’Ëæ∫¡“∑∫∑«π ‡æ◊ËÕ𔉪 Ÿà°“√
ªÑÕß°—π·≈–æ—≤π“°“√¥Ÿ·≈ºŸâªÉ«¬
§«√À“ ∂“π∑’Ë∑’ˇÀ¡“– ¡„π°“√¥Ÿ·≈ ‚¥¬°“√¥Ÿ·≈∑’Ë ”§—≠
§◊Õ欓¬“¡ªÑÕß°—π¿“«– hypoxia ·≈– hypo/hypercarbia §«√
¡’°“√√—°…“√–¥—∫‡°≈◊Õ·√à„À⪰µ‘ À≈’°‡≈’¬Ë ß°“√„™â¬“πÕπÀ≈—∫
¬“À¬àÕπ°≈â“¡‡π◊ÈÕ‚¥¬‰¡à®”‡ªìπ √—°…“Õ“°“√™—° „À⬓√—°…“
À—«„®‡µâπº‘¥ª°µ‘µàÕ‡¡◊ËÕ¡’¢âÕ∫àß™’È à«πÕÿ≥À¿Ÿ¡‘°“¬π—Èπ°√≥’
√Ÿª∑’Ë 1 · ¥ß·π«∑“ß ventricular fibrillation ·≈– pulseless ventricular tachycardia 6
√Ÿª∑’Ë 2 · ¥ß·π«∑“ß asystole ·≈– pulseless electrical activity 6
√ÿª
2. Silber JH, Kennedy SK, Even-Shoshan O, Chen W, Koziol LF,
Showan AM, et al. Anesthesiologist direction and
patient outcomes. Anesthesiology 2000; 93:152-63.
3. Robicsek SA, Layon AJ, Gabrielli A. In: Lobato EB, Gravenstein
N, Kirby RR, eds. Complications in anesthesiology. New York:
Wolters Kluwer Lippincott Williums Wilkins, 2008:295-309.
4. Odegard KC, DiNardo JA, Kussman BD, Shukla A, Harrington
J, Casta A, et al. The frequency of anesthesia-related cardiac
arrests in patients with congenital heart disease undergoing
cardiac surgery. Anesth Analg 2007; 105:335-43.
5. Flick RP, Sprung J, Harrison TE, Gleich SJ, Schroeder DR,
Hanson AC, et al. Perioperative cardiac arrests in
children between 1988 and 2005 at a tertiary referral center:
a study of 92,881 patients. Anesthesiology 2007; 106:226-37.
¿“«–À—«„®À¬ÿ¥‡µâπ·∫∫‰¡à§“¥§‘¥‡ªìπ¿“«–∑’Ë∫ÿ§≈“°√
∑ÿ ° §π “¡“√∂æ∫‰¥â “¡“√∂À≈’ ° ‡≈’Ë ¬ ß¿“«–¥— ß °≈à “ «
‚¥¬°“√¥Ÿ · ≈ºŸâ ªÉ « ¬µ“¡¡“µ√∞“πÕ¬à “ ߇À¡“– ¡∑—È ß °“√
ª√–‡¡‘π·≈–‡µ√’¬¡ºŸâªÉ«¬‰ª®π∂÷ß°“√«“߬“√–ß—∫§«“¡√Ÿâ ÷°
·≈–°“√¥Ÿ·≈À≈—ßºà“µ—¥ ´÷Ëß∫ÿ§≈“°√§«√¡’§«“¡‡¢â“„®„π
«‘ ∏’ ° “√ªÑ Õ ß°— π ∂“π°“√≥å ∑’Ë ¡’ § «“¡‡ ’Ë ¬ ß·≈–°“√¥Ÿ · ≈
‡¡◊ËÕ‡°‘¥Õÿ∫—µ‘°“√≥åÕ¬à“߇À¡“– ¡
‡Õ° “√Õâ“ßÕ‘ß
1. Lagasse RS. Anesthesia safety: model or myth? A review of
the published literature and analysis of current original data.
Anesthesiology 2002; 97:1609-17.
220
»√’π§√‘π∑√凫™ “√ 2551; 23(2)
•
Srinagarind Med J 2008; 23(2)
æ≈æ—π∏å ∫ÿ≠¡“°
•
17. Biboulet P, Aubas P, Dubourdieu J, Rubenovitch J, Capdevila
X, dûAthis F. Fatal and non fatal cardiac arrests related to
anesthesia. Can J Anaesth 2001; 48:326-32.
18. Bhananker SM, Ramamoorthy C, Geiduschek JM, Posner KL,
Domino KB, Haberkern CM, et al. Anesthesia-related
cardiac arrest in children: update from the Pediatric
Perioperative Cardiac Arrest Registry. Anesth Analg 2007;
105:344-50.
19. Bunchungmongkol N, Somboonviboon W, Suraseranivongse S,
Vasinanukorn M, Chau-in W, Hintong T. Pediatric anesthesia
adverse events: the Thai Anesthesia Incidents Study (THAI
Study) database of 25,098 cases. J Med Assoc Thai 2007;
90:2072-9.
20. Boonmak P, Boonmak S, Srichaipanha S, Thincheelong V.
Incidence of anesthesia-associated cardiac arrest and related
factors at Srinagarind hospital. Srinagarind Med J 2005;
20: 63-9.
21. Kopp SL, Horlocker TT, Warner ME, Hebl JR, Vachon CA,
Schroeder DR, et al. Cardiac arrest during neuraxial anesthesia:
frequency and predisposing factors associated with survival.
Anesth Analg 2005; 100:855-65.
22. Auroy Y, Benhamou D, Bargues L, Ecoffey C, Falissard B,
Mercier FJ, et al. Major complications of regional anesthesia
in France: The SOS Regional Anesthesia Hotline Service.
Anesthesiology 2002; 97:1274-80.
23. Charuluxananan S, Thienthong S, Rungreungvanich M,
Chanchayanon T, Chinachoti T, Kyokong O, et al. The Thai
Anesthesia Incidents Study (THAI study) of morbidity after
spinal anesthesia: a multi-centered registry of 40, 271
anesthetics. J Med Assoc Thai 2007; 90:1150-60.
24. Pollard JB. Cardiac arrest during spinal anesthesia: common
mechanisms and strategies for prevention. Anesth Analg 2001;
92:252-6.
25. Carpenter RL, Caplan RA, Brown DL, Stephenson C, Wu R.
Incidence and risk factors for side effects of spinal
anesthesia. Anesthesiology 1992; 76:906-16.
26. Lesser JB, Sanborn KV, Valskys R, Kuroda M. Severe
bradycardia during spinal and epidural anesthesia recorded by
an anesthesia information management system.
Anesthesiology 2003; 99:859-66.
27. Kyokong O, Charuluxananan S, Sriprajittichai P, Poomseetong
T, Naksin P. The incidence and risk factors of hypotension
and bradycardia associated with spinal anesthesia. J Med
Assoc Thai 2006; 89:S58-64.
6. American Heart Association. Advanced Cardiopulmonary Life
Support (provider manual) 2006.
7. Newland MC, Ellis SJ, Lydiatt CA, Peters KR, Tinker JH,
Romberger DJ, Ullrich FA, Anderson JR. Anesthetic-related
cardiac arrest and its mortality: a report covering 72,959
anesthetics over 10 years from a US teaching hospital.
Anesthesiology 2002; 97:108-15.
8. Sprung J, Warner ME, Contreras MG, Schroeder DR,
Beighley CM, Wilson GA, et al. Predictors of survival
following cardiac arrest in patients undergoing noncardiac
surgery: a study of 518,294 patients at a tertiary referral
center. Anesthesiology 2003; 99:259-69.
9. Kawashima Y, Takahashi S, Suzuki M, Morita K, Irita K,
Iwao Y, et al. Anesthesia-related mortality and morbidity
over a 5-year period in 2,363,038 patients in Japan. Acta
Anaesthesiol Scand 2003; 47:809-17.
10. Posner KL, Geiduschek J, Haberkern CM, Ramamoorthy C,
Hackel A, Morray JP. Unexpected cardiac arrest among
children during surgery, a North American registry to
elucidate the incidence and causes of anesthesia related
cardiac arrest. Qual Saf Health Care 2002; 11:252-7.
11. Charuluxananan S, Chinachoti T, Pulnitiporn A, Klanarong S,
Rodanant O, Tanudsintum S. The Thai Anesthesia Incidents
Study (THAI Study) of perioperative death: analysis of risk
factors. J Med Assoc Thai 2005; 88 Suppl 7:S30-40.
12. American Heart Association. Pediatric Cardiopulmonary Life
Support (course guide) 2006.
13. Aroonpruksakul N, Raksakiatisak M, Thapenthai Y,
Wangtawesaup K, Chaiwat O, Vacharaksa K, et al. Perioperative
cardiac arrest at Siriraj Hospital between 1999-2001. J Med
Assoc Thai 2002; 85:S993-9.
14. Boonmak P, Boonmak S, Sathitkarnmanee T, Chau-in W,
Nonlhaopol D, Thananun M. Surveillance of Anesthetic
Related Complications at Srinagarind†Hospital, Khon†Kaen
†University, Thailand. J Med Assoc Thai 2005; 88:613-21.
15. Currie M, Mackay P, Morgan C, Runciman WB, Russell WJ,
Sellen A, et al. The Australian Incident Monitoring Study.
The çwrong drugé problem in anaesthesia: an analysis of
2000 incident reports. Anaesth Intensive Care 1993;
21:596-601.
16. Morgan CA, Webb RK, Cockings J, Williamson JA. The
Australian Incident Monitoring Study. Cardiac arrest-an analysis of 2000 incident reports. Anaesth Intensive Care
1993; 21:626-37.
»√’π§√‘π∑√凫™ “√ 2551; 23(2)
Polpun Boonmak
•
Srinagarind Med J 2008; 23(2)
221
¿“«–À—«„®À¬ÿ¥‡µâπ∑’ˉ¡à§“¥§‘¥·≈–«‘ ≠
— ≠’«‘∑¬“
•
35. Boonmak P, Boonmak S, Srichaipanha S, Poomsawat S.
Knowledge and skill after brief ACLS training. J Med Assoc
Thai 2004; 87:1311-4.
36. Tinker JH, Dull DL, Caplan RA, Ward RJ, Cheney FW. Role of
monitoring devices in prevention of anesthetic mishaps:
a closed claims analysis. Anesthesiology 1989; 71:541-6.
37. Fleisher LA, Eagle KA. Clinical practice. Lowering cardiac risk
in noncardiac surgery. N Engl J Med 2001; 345:1677-82.
38. Arbous MS, Meursing AE, van Kleef JW, de Lange JJ,
Spoormans HH, Touw P, et al. Impact of anesthesia
management characteristics on severe morbidity and
mortality. Anesthesiology 2005; 102:257-68.
39. Suraseranivongse S, Somprakit P, Soontranant P, Katesumparn
Y, Wongchuengam W. Factors influencing CPR outcome in
Siriraj Hospital. J Med Assoc Thai 1998; 81:835-43.
40. Rubens DD, Geiduschek JM. Intraoperative cardiac arrest.
In: Atlee JL, ed. Complications in Anesthesia. New York:
Saunders Elsevier, 2007:615-8.
28. Ngan Kee WD. Confidential enquiries into maternal deaths:
50 years of closing the loop. Br J Anaesth 2005; 94:413-6.
29. Stienstra R. Mechanisms behind and treatment of sudden,
unexpected circulatory collapse during central neuraxis
blockade. Acta Anaesthesiol Scand 2000; 44:965-71.
30. Gobbo Braz L, Braz JR, Modolo NS, do Nascimento P, Brushi
BA, Raquel de Carvalho L. Perioperative cardiac arrest and
its mortality in children. A 9-year survey in a Brazilian tertiary
teaching hospital. Paediatr Anaesth 2006; 16:860-6.
31. Rodanant O, Hintong T, Chua-in W, Tanudsintum S, Sirinanmd
C, Kyokong O. The Thai anesthesia incidents study (THAI
Study) of perioperative death in geriatric patients. J Med Assoc
Thai 2007; 90:1375-81.
32. √“™«‘∑¬“≈—¬«‘ ≠
— ≠’·æ∑¬å·Ààߪ√–‡∑»‰∑¬.°“√ª√–‡¡‘πºŸªâ «É ¬
°àÕπ„À⬓√–ß—∫§«“¡√Ÿâ ÷°.
33. √“™«‘∑¬“≈—¬«‘ —≠≠’·æ∑¬å·Ààߪ√–‡∑»‰∑¬.·π«∑“ß„π°“√
„Àâ∫√‘°“√∑“ß«‘ —≠≠’.
34. Akavipat P, Ittichaikulthol W, Tuchinda L, Sothikarnmanee T,
Klanarong S, Pranootnarabhal T. The Thai Anesthesia
Incidents (THAI Study) of anesthetic risk factors related to
perioperative death and perioperative cardiovascular
complications in intracranial surgery. J Med Assoc Thai 2007;
90:1565-72
222
»√’π§√‘π∑√凫™ “√ 2551; 23(2)
Unexpected Cardiac Arrest and Anesthesia
•
Srinagarind Med J 2008; 23(2)